The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Kaposi sarcoma herpesvirus (KSHV) subtypes and impact on survival in 107 patients with Kaposi sarcoma and other KSHV-associated diseases.
 
Jose Mercado-Matos
No Relationships to Disclose
 
Vickie Marshall
No Relationships to Disclose
 
Elena Cornejo Castro
No Relationships to Disclose
 
Wendell Miley
No Relationships to Disclose
 
Nazzarena Labo
No Relationships to Disclose
 
Romin Roshan
No Relationships to Disclose
 
Matthew Witterholt
No Relationships to Disclose
 
Robert Yarchoan
Research Funding - Bristol-Myers Squibb/Celgene (Inst); CTI BioPharma Corp (Inst); EMD Serono (Inst); Janssen Research & Development (Inst); Lentigen Technology (Inst); Lilly (Inst); Merck (Inst); PDS Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to increase in immune surface markers by pomalidomide, lenalidomide and related drugs in patients with KSHV-associated diseases (Inst); Patent(s) on the treatment of HIV and hepatitis virus with an antiviral drug and a vaccine to prevent resistance (Inst); Patents on the treatment of Kaposi sarcoma with IL-12 (Inst); Various patents including patents on anti-HIV therapies and soluble IL-2 receptor; mostly expired. (Inst); Various patents on vasostatin, KSHV vIL-6, internalization of surface markers, calreticulin, and calreticulin fragments (Inst)
 
Kathryn Lurain
Research Funding - Bristol-Myers Squibb/Celgene (Inst); CTI BioPharma Corp (Inst); EMD Serono (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Miltenyi Biotec (Inst)
 
Ramya Ramaswami
Research Funding - Celgene (Inst); CTI BioPharma Corp (Inst); EMD Serono (Inst); Genentech (Inst); Merck Serono (Inst)
 
Denise Whitby
No Relationships to Disclose